1-6 of 6
Yelena Zabelina
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel

Sharyn D. Baker, Ming Zhao, Carlton K. K. Lee, Jaap Verweij, Yelena Zabelina, Julie R. Brahmer, Antonio C. Wolff, Alex Sparreboom, Michael A. Carducci
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (6): 1976–1983.
https://doi.org/10.1158/1078-0432.CCR-0842-03
Published: 24 March 2004
View article titled, Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel
Open the PDF for Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel in another window
Journal Articles

Phase I Study of Docosahexaenoic Acid-Paclitaxel: a Taxane-Fatty Acid Conjugate with a Unique Pharmacology and Toxicity Profile

Antonio C. Wolff, Ross C. Donehower, M. Katherine Carducci, Michael A. Carducci, Julie R. Brahmer, Yelena Zabelina, Matthews O. Bradley, Forrest H. Anthony, Charles S. Swindell, Philip A. Witman, Nigel L. Webb, Sharyn D. Baker
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3589–3597.
Published: 23 September 2003
View article titled, Phase I Study of Docosahexaenoic Acid-Paclitaxel: <subtitle>a Taxane-Fatty Acid Conjugate with a Unique Pharmacology and Toxicity Profile</subtitle>
Open the PDF for Phase I Study of Docosahexaenoic Acid-Paclitaxel: <subtitle>a Taxane-Fatty Acid Conjugate with a Unique Pharmacology and Toxicity Profile</subtitle> in another window
Journal Articles

Disposition of Docosahexaenoic Acid-Paclitaxel, a Novel Taxane, in Blood: In Vitro and Clinical Pharmacokinetic Studies

Alex Sparreboom, Antonio C. Wolff, Jaap Verweij, Yelena Zabelina, Desiree M. van Zomeren, Gregory L. McIntire, Charles S. Swindell, Ross C. Donehower, Sharyn D. Baker
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (1): 151–159.
Published: 01 January 2003
View article titled, Disposition of Docosahexaenoic Acid-Paclitaxel, a Novel Taxane, in Blood: <subtitle> <em>In Vitro</em> and Clinical Pharmacokinetic Studies</subtitle>
Open the PDF for Disposition of Docosahexaenoic Acid-Paclitaxel, a Novel Taxane, in Blood: <subtitle> <em>In Vitro</em> and Clinical Pharmacokinetic Studies</subtitle> in another window
Journal Articles

Phase I Study of N 1, N 11-Diethylnorspermine in Patients with Non-Small Cell Lung Cancer

Hillary A. Hahm, David S. Ettinger, Kathy Bowling, Beth Hoker, Tian Ling Chen, Yelena Zabelina, Robert A. Casero, Jr.
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (3): 684–690.
Published: 01 March 2002
View article titled, Phase I Study of <em>N</em> <sup>1</sup>, <em>N</em> <sup>11</sup>-Diethylnorspermine in Patients with Non-Small Cell Lung Cancer
Open the PDF for Phase I Study of <em>N</em> <sup>1</sup>, <em>N</em> <sup>11</sup>-Diethylnorspermine in Patients with Non-Small Cell Lung Cancer in another window
Journal Articles

A Phase I Clinical and Pharmacological Evaluation of Sodium Phenylbutyrate on an 120-h Infusion Schedule

Michael A. Carducci, Jill Gilbert, M. Katherine Bowling, Dennis Noe, Mario A. Eisenberger, Victoria Sinibaldi, Yelena Zabelina, Tian-ling Chen, Louise B. Grochow, Ross C. Donehower
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (10): 3047–3055.
Published: 01 October 2001
View article titled, A Phase I Clinical and Pharmacological Evaluation of Sodium Phenylbutyrate on an 120-h Infusion Schedule
Open the PDF for A Phase I Clinical and Pharmacological Evaluation of Sodium Phenylbutyrate on an 120-h Infusion Schedule in another window
Journal Articles

A Phase I Dose Escalation and Bioavailability Study of Oral Sodium Phenylbutyrate in Patients with Refractory Solid Tumor Malignancies

Jill Gilbert, Sharyn D. Baker, M. Katherine Bowling, Louise Grochow, W. Douglas Figg, Yelena Zabelina, Ross C. Donehower, Michael A. Carducci
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2292–2300.
Published: 01 August 2001
View article titled, A Phase I Dose Escalation and Bioavailability Study of Oral Sodium Phenylbutyrate in Patients with Refractory Solid Tumor Malignancies
Open the PDF for A Phase I Dose Escalation and Bioavailability Study of Oral Sodium Phenylbutyrate in Patients with Refractory Solid Tumor Malignancies in another window